Top member reports
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
#quarterly 4c
stale
Clinuvel have achieved a record quarter with Net operating cashflow of $18,478.00 from cash receipts of $24,503.00.
The market has continued to trade Clinuvel the same as other cash burning biotechs. This company has a proven niche product, which is cash generative and using this cash to fund trials and clinical programs for a range of other treatments.
See announcement here.
